AGRX - Agile Therapeutics Non-GAAP EPS of -$0.63 revenue of $5.7M
2024-05-15 16:58:52 ET
More on Agile Therapeutics
- Agile Therapeutics, Inc. (AGRX) Q4 2023 Earnings Call Transcript
- Agile Therapeutics Q4 2023 Earnings Preview
- Agile Therapeutics announces delisting from Nasdaq
- Financial information for Agile Therapeutics